Authors: | Eguia, E.; Baker, T.; Baker, M. |
Article Title: | Hepatocellular carcinoma: Surgical management and evolving therapies |
Abstract: | Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common cancer in women worldwide. It is also the second leading cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250–261, 2020 [1]). © The Author(s), under exclusive license to Springer Nature Switzerland AG 2024. |
Keywords: | cancer surgery; liver cell carcinoma; liver transplantation; multimodality cancer therapy; patient selection; carcinoma, hepatocellular; liver neoplasms; cancer staging; cancer diagnosis; cancer palliative therapy; cancer immunotherapy; cancer prevention; cancer therapy; liver tumor; cancer immunization; surgery; hepatectomy; comparative effectiveness; procedures; humans; human |
Journal Title: | Cancer Treatment and Research |
Volume: | 192 |
ISSN: | 0927-3042 |
Publisher: | Springer |
Date Published: | 2024-01-01 |
Start Page: | 185 |
End Page: | 206 |
Language: | English |
DOI: | 10.1007/978-3-031-61238-1_10 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Chapter 10 in "Gastrointestinal Malignancies. 2nd ed" (ISBN: 978-3-031-61237-4) -- Source: Scopus |